Similarly, it predicts that more aggressive tumors such as castration resistant prostate cancer express higher level of ATAD2 compared to primary adenocarcinoma due to higher mitotic index as seen in Supplementary Figure S1A. This evidence concerns the gene ATAD2 and Familial prostate cancer.